Literature DB >> 26847090

Tumefactive Demyelinating Lesions in Multiple Sclerosis and Associated Disorders.

Meredith C Frederick1,2, Michelle H Cameron3,4.   

Abstract

Tumefactive demyelinating lesions are rare consequences of central nervous system (CNS) idiopathic inflammatory demyelinating diseases. Tumefactive demyelinating lesions pose a diagnostic challenge because they can mimic tumors and abscesses and because they can be caused by a heterogeneous range of disorders. This article reviews the recent literature on the clinical presentation; radiographic features; prognosis; and management of tumefactive demyelinating lesions in multiple sclerosis, acute demyelinating encephalomyelitis, neuromyelitis optica, and the rare variants of multiple sclerosis including Schilder's disease, Marburg acute multiple sclerosis, and Balo's concentric sclerosis.

Entities:  

Keywords:  Balo’s concentric sclerosis; Marburg; Schilder’s disease; Tumefactive multiple sclerosis

Mesh:

Year:  2016        PMID: 26847090     DOI: 10.1007/s11910-016-0626-9

Source DB:  PubMed          Journal:  Curr Neurol Neurosci Rep        ISSN: 1528-4042            Impact factor:   5.081


  56 in total

1.  Demyelinating lesions with features of Balo's concentric sclerosis in a patient with active hepatitis C and human herpesvirus 6 infection.

Authors:  D Ferreira; S Castro; G Nadais; J M Dias Costa; J M Fonseca
Journal:  Eur J Neurol       Date:  2010-09-16       Impact factor: 6.089

2.  Decompressive hemicraniectomy for tumefactive demyelination with transtentorial herniation: observation.

Authors:  Brian T Ragel; Daniel R Fassett; J Richard Baringer; Samuel R Browd; Andrew T Dailey
Journal:  Surg Neurol       Date:  2006-06

3.  Neuromyelitis optica and concentric rings of Baló in the brainstem.

Authors:  Jerome J Graber; Ilya Kister; Howard Geyer; Mausumi Khaund; Joseph Herbert
Journal:  Arch Neurol       Date:  2009-02

4.  Early relapse with tumefactive MS lesion upon initiation of fingolimod therapy.

Authors:  Sabina Boangher; Sophie Goffette; Vincent Van Pesch; Pascal Mespouille
Journal:  Acta Neurol Belg       Date:  2015-06-14       Impact factor: 2.396

5.  High dose cyclophosphamide treatment in Marburg variant multiple sclerosis A case report.

Authors:  Kenkichi Nozaki; Nada Abou-Fayssal
Journal:  J Neurol Sci       Date:  2010-06-25       Impact factor: 3.181

6.  Large focal tumor-like demyelinating lesions of the brain: intermediate entity between multiple sclerosis and acute disseminated encephalomyelitis? A study of 31 patients.

Authors:  J J Kepes
Journal:  Ann Neurol       Date:  1993-01       Impact factor: 10.422

Review 7.  Tumefactive demyelination: an approach to diagnosis and management.

Authors:  Todd A Hardy; Jeremy Chataway
Journal:  J Neurol Neurosurg Psychiatry       Date:  2013-01-19       Impact factor: 10.154

8.  How to treat tumefactive demyelinating disease?

Authors:  Volker Siffrin; Wibke Müller-Forell; Harald von Pein; Frauke Zipp
Journal:  Mult Scler       Date:  2013-12-17       Impact factor: 6.312

9.  Biopsy Proven Tumefactive Multiple Sclerosis with Concomitant Glioma: Case Report and Review of the Literature.

Authors:  Esteban E Golombievski; Matthew A McCoyd; John M Lee; Michael J Schneck
Journal:  Front Neurol       Date:  2015-07-17       Impact factor: 4.003

10.  Primary central nervous system lymphoma with preceding spontaneous pseudotumoral demyelination in an immunocompetent adult patient: A case report and literature review.

Authors:  Junkoh Yamamoto; Shohei Shimajiri; Yoshiteru Nakano; Shigeru Nishizawa
Journal:  Oncol Lett       Date:  2014-04-04       Impact factor: 2.967

View more
  8 in total

Review 1.  The current role of MRI in differentiating multiple sclerosis from its imaging mimics.

Authors:  Ruth Geraldes; Olga Ciccarelli; Frederik Barkhof; Nicola De Stefano; Christian Enzinger; Massimo Filippi; Monika Hofer; Friedemann Paul; Paolo Preziosa; Alex Rovira; Gabriele C DeLuca; Ludwig Kappos; Tarek Yousry; Franz Fazekas; Jette Frederiksen; Claudio Gasperini; Jaume Sastre-Garriga; Nikos Evangelou; Jacqueline Palace
Journal:  Nat Rev Neurol       Date:  2018-03-09       Impact factor: 42.937

2.  Population-based incidence and clinico-radiological characteristics of tumefactive demyelination in Olmsted County, Minnesota, United States.

Authors:  Mahboubeh Fereidan-Esfahani; Paul A Decker; Jeanette E Eckel Passow; Claudia F Lucchinetti; Eoin Patrick Flanagan; William Oliver Tobin
Journal:  Eur J Neurol       Date:  2021-12-09       Impact factor: 6.089

Review 3.  Autoimmune diseases of the brain, imaging and clinical review.

Authors:  Ghazal Shadmani; Tyrell J Simkins; Reza Assadsangabi; Michelle Apperson; Lotfi Hacein-Bey; Osama Raslan; Vladimir Ivanovic
Journal:  Neuroradiol J       Date:  2021-09-07

4.  Recurrent Fulminant Tumefactive Demyelination With Marburg-Like Features and Atypical Presentation: Therapeutic Dilemmas and Review of Literature.

Authors:  Aigli G Vakrakou; Dimitrios Tzanetakos; Theodore Argyrakos; Georgios Koutsis; Maria-Eleptheria Evangelopoulos; Elisabeth Andreadou; Maria Anagnostouli; Marianthi Breza; John S Tzartos; Elias Gialafos; Antonios N Dimitrakopoulos; Georgios Velonakis; Panagiotis Toulas; Leonidas Stefanis; Constantinos Kilidireas
Journal:  Front Neurol       Date:  2020-06-30       Impact factor: 4.003

5.  When tumefactive demyelination is truly a tumor: case report of a radiographic misdiagnosis.

Authors:  Breanna Taylor; Mallika P Patel; Katherine B Peters
Journal:  CNS Oncol       Date:  2021-01-15

6.  Balo's Concentric Sclerosis Mimicking Tumor on Magnetic Resonance Imaging in a Young Patient.

Authors:  Van Trung Hoang; Cong Thao Trinh; Hoang Anh Thi Van; Thanh Tam Thi Nguyen; Vichit Chansomphou; Ngoc Trinh Thi Pham; Minh Tri Thi Vo; Hoang Quan Nguyen; Duc Thanh Hoang
Journal:  Clin Med Insights Case Rep       Date:  2021-01-19

7.  Recurrent tumefactive demyelinating lesions in an elderly woman.

Authors:  Erika L Weil; Mohammad Obadah Nakawah
Journal:  Radiol Case Rep       Date:  2022-09-28

8.  Progressive Tumefactive Demyelination as the Only Result of Extensive Diagnostic Work-Up: A Case Report.

Authors:  Pavel Štourač; Jan Kolčava; Miloš Keřkovský; Tereza Kopřivová; Leoš Křen; Josef Bednařík
Journal:  Front Neurol       Date:  2021-07-08       Impact factor: 4.003

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.